<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01734356</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/10/11-P</org_study_id>
    <nct_id>NCT01734356</nct_id>
  </id_info>
  <brief_title>Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells</brief_title>
  <acronym>Diag-iPS</acronym>
  <official_title>Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <brief_summary>
    <textblock>
      The recent developments of research on iPS (induced pluripotent stem) cells lead to the
      establishment of mature cell lines such as cardiomyocytes or valvular interstitial cells with
      genetic and cellular characteristics of the donors. These cells represent a biological
      material more readily available to identify the pathophysiological mechanisms involved in the
      diseases of BrS or ERS patients, which will lead to the identification of genetic markers.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Production of cardiomyocytes modele from skin fibroblast of arrhythmic patient</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Production of valve interstitial cells modele from skin fibroblast of patient with a valvulopathy</measure>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inherited Arrhythmias and Valvulopathies</condition>
  <arm_group>
    <arm_group_label>inherited arrhythmias</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>6 patient with inherited arrhythmias</description>
  </arm_group>
  <arm_group>
    <arm_group_label>valvulopathies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>6 patient with valvulopathies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controle</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>8 healthy people for these pathologies</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Skin biopsies</intervention_name>
    <arm_group_label>inherited arrhythmias</arm_group_label>
    <arm_group_label>valvulopathies</arm_group_label>
    <arm_group_label>controle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patient with a family history of inherited arrhythmia or valvulopathy

          -  Age : 22-60 yo.

          -  patient no confine to bed

          -  Male or female

          -  Written consent

          -  Patient affiliated to the French social security

        Exclusion criteria:

          -  Pregnant woman

          -  Patient under 22 yo or adults under guardianship

          -  Indication against local anesthesia

          -  Anticoagulant treatment

          -  Absence or positivity of HIV, HBV, HCV serology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent PROBST</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes UH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2012</study_first_submitted>
  <study_first_submitted_qc>November 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2012</study_first_posted>
  <last_update_submitted>November 6, 2014</last_update_submitted>
  <last_update_submitted_qc>November 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>iPS</keyword>
  <keyword>fibroblast</keyword>
  <keyword>arrhythmias</keyword>
  <keyword>valvulopathies</keyword>
  <keyword>electrophysiology</keyword>
  <keyword>genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

